Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inspire Veterinary Partners (IVPR) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for Inspire Veterinary Partners (IVPR) over the last 4 years, with Q3 2025 value amounting to -$2.5 million.

  • Inspire Veterinary Partners' Consolidated Net Income rose 2760.0% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year increase of 1729.32%. This contributed to the annual value of -$14.3 million for FY2024, which is 357.35% up from last year.
  • According to the latest figures from Q3 2025, Inspire Veterinary Partners' Consolidated Net Income is -$2.5 million, which was up 2760.0% from -$3.0 million recorded in Q2 2025.
  • Inspire Veterinary Partners' 5-year Consolidated Net Income high stood at -$1.2 million for Q2 2023, and its period low was -$7.9 million during Q3 2023.
  • Its 4-year average for Consolidated Net Income is -$3.1 million, with a median of -$3.0 million in 2025.
  • In the last 5 years, Inspire Veterinary Partners' Consolidated Net Income tumbled by 46021.19% in 2023 and then skyrocketed by 5574.17% in 2024.
  • Over the past 4 years, Inspire Veterinary Partners' Consolidated Net Income (Quarter) stood at -$1.9 million in 2022, then plummeted by 114.16% to -$4.1 million in 2023, then increased by 4.23% to -$4.0 million in 2024, then skyrocketed by 36.31% to -$2.5 million in 2025.
  • Its last three reported values are -$2.5 million in Q3 2025, -$3.0 million for Q2 2025, and -$2.4 million during Q1 2025.